| Resimac Group Limited (RMC) ORDINARY FULLY PAID |
Financials |
$380 |
Update - Notification of buy-back - RMC
|
2 May 2025 9:21AM |
$0.820 |
$0.960 |
risen by
17.07%
|
|
| Jade Gas Holdings Limited (JGH) ORDINARY FULLY PAID |
Energy |
$55 |
ASX Waiver Request Granted
|
2 May 2025 9:19AM |
$0.037 |
$0.030 |
fallen by
18.92%
|
|
| Equinox Resources Limited (EQN) ORDINARY FULLY PAID |
Materials |
$12 |
Proposed issue of securities - EQN
|
2 May 2025 9:18AM |
$0.115 |
$0.080 |
fallen by
30.43%
|
|
| Equinox Resources Limited (EQN) ORDINARY FULLY PAID |
Materials |
$12 |
$3m Raise Positions EQN to Deliver Near-Term Milestones
|
2 May 2025 9:18AM |
$0.115 |
$0.080 |
fallen by
30.43%
|
|
EQN - Price-sensitive ASX Announcement
Full Release
Key Points
- Equinox Resources secures A$3 million via a two-tranche placement.
- Funds will support project milestones and general working capital.
- Placement priced at A$0.095 per share with options attached.
- Strong demand reflects investor confidence in Equinox's strategy.
- Focus on titanium, antimony, and iron ore assets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Investa Office Fund (IOF) ORDINARY FULLY PAID |
Real Estate |
- |
mFund - Fund Profile - IOF01
|
2 May 2025 9:17AM |
$5.580 |
$5.580 |
fallen by
0%
|
|
| Pengana Capital Group Limited (PCG) ORDINARY FULLY PAID |
Financials |
$64 |
Update - Notification of buy-back - PCG
|
2 May 2025 9:16AM |
$0.750 |
$0.655 |
fallen by
12.67%
|
|
| Forbidden Foods Limited (FFF) ORDINARY FULLY PAID |
Consumer Staple |
$4 |
Trading update on April sales performance
|
2 May 2025 9:16AM |
$0.007 |
$0.006 |
fallen by
14.29%
|
|
FFF - Price-sensitive ASX Announcement
Full Release
Key Points
- Invoiced sales in April of $445,961, a gain of 218% from the prior year comparative period.
- Ecommerce sales for Blue Dinosaur products saw monthly online sales of $123,165, a gain of 300% from the prior year.
- The company is on track to exceed $1 million in quarterly net sales for the third consecutive quarter.
- April's sales total followed invoiced sales of +$532,000 in March 2025, marking the highest monthly sales since July 2023.
- The company plans to change its name to OMG Group Limited to strengthen its brand position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bell Financial Group Limited (BFG) ORDINARY FULLY PAID |
Financials |
$422 |
Addendum to Notice of Annual General Meeting/Proxy Form
|
2 May 2025 9:16AM |
$1.255 |
$1.315 |
risen by
4.78%
|
|
| Codrus Minerals Limited (CDR) ORDINARY FULLY PAID |
Materials |
$4 |
Drill Permit Received, High Grade Bull Run Gold Project USA
|
2 May 2025 9:15AM |
$0.020 |
$0.017 |
fallen by
15%
|
|
CDR - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling permit approved for Bull Run Gold Project in Oregon, USA.
- Permit allows for 30 drill holes totaling 14,000 meters.
- Project has proven production history since 1929.
- Historical drilling returned intercepts of 20.5m at 3.53g/t Au.
- Rock sampling results included up to 1,040 g/t Au.
- Upcoming drilling will focus on priority targets with further resource definition planned.
- Project is supported by historical mining activity in the region.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Goodman Fielder Limited (GFF) ORDINARY FULLY PAID |
Consumer Staple |
- |
mFund - Fund Profile - GFF01
|
2 May 2025 9:14AM |
$0.670 |
$0.670 |
fallen by
0%
|
|
| AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$14 |
Change of registered address
|
2 May 2025 9:13AM |
$0.005 |
$0.006 |
risen by
20%
|
|
| Articore Group Limited (ATG) ORDINARY FULLY PAID |
Consumer Discretionary |
$70 |
Update - Notification of buy-back - ATG
|
2 May 2025 9:11AM |
$0.155 |
$0.240 |
risen by
54.84%
|
|
| Asian Masters Fund Limited (AUF) ORDINARY FULLY PAID |
Financials |
- |
mFund - Fund Profile - AUF01
|
2 May 2025 9:10AM |
$1.280 |
$1.280 |
fallen by
0%
|
|
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$2,739 |
Update - Notification of buy-back - ORA
|
2 May 2025 9:10AM |
$1.840 |
$2.220 |
risen by
20.65%
|
|
| Greenvale Energy Limited (GRV) ORDINARY FULLY PAID |
Energy |
$25 |
Greenvale to Commence Alpha Test Program 7
|
2 May 2025 9:09AM |
$0.050 |
$0.042 |
fallen by
16%
|
|
GRV - Price-sensitive ASX Announcement
Full Release
Key Points
- Monash University has been re-engaged to commence Test Program 7.
- The purpose of Test Program 7 is to produce bulk samples using optimized parameters from Test Program 6.
- Bulk samples will be produced with toluene as carrier and various catalysts, and THF without a catalyst.
- Bulk samples will be sent to Technix in New Zealand for identification and product certification.
- The total budgeted cost for Test Program 7 is $622,000.
- The first part of Test Program 7 involves modifying test apparatus in the Monash liquefaction laboratory.
- The modifications are expected to take six to eight weeks before the six-month test program begins.
- The goal is to produce as many bulk samples as possible within the six-month timeframe.
- Greenvale aims to produce a high-grade C170 bitumen product.
- Progress is being made towards achieving viscosity levels required for C170 certification.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Meridian Energy Limited (MEZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Utilities |
$12,666 |
D&O Initial Disclosure Notice
|
2 May 2025 9:09AM |
$5.230 |
$4.800 |
fallen by
8.22%
|
|
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$2,376 |
Neuren appoints Daryl DeKarske to executive team
|
2 May 2025 9:09AM |
$11.800 |
$18.760 |
risen by
58.98%
|
|
| AMP Capital China Growth Fund (AGF) ORDINARY FULLY PAID |
Financials |
- |
mFund - Fund Profile - AGF01
|
2 May 2025 9:08AM |
$0.360 |
$0.360 |
fallen by
0%
|
|
| Viking Mines Limited (VKA) ORDINARY FULLY PAID |
Materials |
$15 |
VKA INTERSECTS HIGH GRADE VISIBLE GOLD IN RIVERINA EAST
|
2 May 2025 9:08AM |
$0.007 |
$0.009 |
risen by
28.57%
|
|
VKA - Price-sensitive ASX Announcement
Full Release
Key Points
- Viking has intersected high-grade visible gold at Riverina East with significant intercepts in drill hole VKRC0180.
- Notable intercepts include 2m at 23.6g/t Au, 1m at 3.2g/t Au, and 1m at 1.5g/t Au.
- The mineralization occurs within broader gold anomalous zones, indicating a significant volume of mineralizing fluid flow.
- Drilling results demonstrate the potential for high-grade gold in an underexplored area of the project.
- Viking holds 25km of strike length along the Zuleika Shear, which is known for multiple significant gold deposits.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$37 |
Update - Notification of buy-back - MEC
|
2 May 2025 9:07AM |
$1.005 |
$1.180 |
risen by
17.41%
|
|
| Macquarie Income Opp Active ETF (Managed Fund) (MQIO) |
Financials |
$86 |
Final Distribution and DRP Issue Price
|
2 May 2025 9:07AM |
$10.650 |
$10.640 |
fallen by
0.09%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,956 |
Appendix 3C
|
2 May 2025 9:07AM |
$49.510 |
$45.220 |
fallen by
8.66%
|
|
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$8 |
Dosing of 1st Six Patients in Phase I/II Skin Cancer Trial
|
2 May 2025 9:05AM |
$0.098 |
$0.090 |
fallen by
8.16%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- First six patients successfully dosed in Phase I/II NMSC trial
- Triggers review by Safety Review Committee for patient safety
- Potential adjustments to trial based on SRC evaluation
- Second clinical site appointed in Queensland
- Invion's drug candidate INV043 is for Photodynamic Therapy
- NMSC makes up over 98% of all skin cancers
- Global treatment market for skin cancer projected to hit US$21.1 billion
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Acrow Limited (ACF) ORDINARY FULLY PAID |
Industrials |
$324 |
Acrow Expands Debt Facility by $20 Million
|
2 May 2025 9:04AM |
$1.050 |
$1.040 |
fallen by
0.95%
|
|
| Wisetech Global Limited (WTC) ORDINARY FULLY PAID |
Information Technology |
$22,944 |
Application for quotation of securities - WTC
|
2 May 2025 9:03AM |
$94.370 |
$68.280 |
fallen by
27.65%
|
|